1,901
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Radiofrequency ablation of liver cancers adjacent to the gallbladder without gallbladder isolation under contrast-enhanced ultrasound monitoring: a preliminary study

, , , , , , , & show all
Pages 139-144 | Received 06 Sep 2018, Accepted 19 Oct 2018, Published online: 29 Nov 2018

References

  • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;10:761–780.
  • European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
  • Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.
  • Kang TW, Kim JM, Rhim H, et al. Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic Resection-Propensity Score analyses of long-term outcomes. Radiology. 2015;275:908–919.
  • Kim GA, Shim JH, Kim MJ, et al. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas. Br J Surg. 2016;103:126–135.
  • Buscarini L, Buscarini E, Di SM, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol. 2001;11:914–921.
  • Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound. 2001;13:159–166.
  • de la Serna S, Vilana R, Sánchez-Cabús S, et al. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience. HPB. 2015;17:387–393.
  • Akahane M, Koga H, Kato N, et al. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics. 2005;25:S57–S68.
  • Chopra S, Dodd GD, Chanin MP, et al. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am J Roentgenol. 2003;180:697–701.
  • Kim JW, Shin SS, Heo SH, et al. Ultrasound-guided percutaneous radiofrequency ablation of liver tumors: how we do it safely and completely. Korean J Radiol. 2015;16:1226–1239.
  • Chen MH, Yang W, Yan K, et al. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging. 2008;33:428–436.
  • Levit E, Bruners P, Gunther RW, et al. Bile aspiration and hydrodissection to prevent complications in hepatic RFA close to the gallbladder. Acta Radiol. 2012;53:1045–1048.
  • Fernandes DD, Shyn PB, Silverman SG. Gallbladder needle decompression during radiofrequency ablation of an adjacent liver tumour. Can Assoc Radiol J. 2012;63:S37–S40.
  • Li M, Yu X, Liang P, et al. Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperth. 2015;31:579–587.
  • Jiang K, Su M, Zhao X, et al. “One-off” complete radiofrequency ablation of hepatocellular carcinoma adjacent to the gallbladder by a novel laparoscopic technique without gallbladder isolation. Cell Biochem Biophys. 2014;68:547–554.
  • Pan WD, Zheng RQ, Nan L, et al. Ultrasound-guided percutaneous microwave coagulation therapy with a “cooled-tip needle” for the treatment of hepatocellular carcinoma adjacent to the gallbladder. Dig Dis Sci. 2010;55:2664–2669.
  • Orlacchio A, Chegai F, Del Giudice C, et al. Radiofrequency thermoablation of HCC larger than 3 cm and less than 5 cm proximal to the gallbladder without gallbladder isolation: a single center experience. Biomed Res Int. 2014;2014:1.
  • Kim SW, Rhim H, Park M, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol. 2009;10:366–376.
  • Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012. Ultraschall in Med. 2012;34:11–29.
  • Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall in Med. 2018;39:e2–44.
  • Salvatore V, Borghi A, Piscaglia F. Contrast-enhanced ultrasound for liver imaging: recent advances. CPD. 2012;18:2236–2252.
  • The Ministry of Health of The People's Republic of China. Diagnosis and therapy criterion for hepatocellular carcinoma (version 2011). Chin Clin Oncol. 2011;2011:929–946.
  • Yokoe M, Hata J, Takada T, et al. Tokyo guideline 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018; 25:41–54.
  • Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: an updated review. WJGPT. 2016;7:477–489.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
  • Lee J, Rhim H, Jeon YH, et al. Radiofrequency ablation of liver adjacent to body of gallbladder: histopathologic changes of gallbladder wall in a pig model. AJR Am J Roentgenol. 2008;190:418–425.
  • Hao Z, Wan C, Han Q, et al. Comparison of the gallbladder damage caused by microwave ablation and cryoablation in vivo porcine livers. Indian J Cancer. 2015;52:84–90.
  • Huang H, Liang P, Yu XL, et al. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperth. 2015;31:40–47.
  • Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005;30:409–418.